~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Friday, April 15, 2016
Allergy Med May Reverse MS Vision Loss
Vision improvement with clemastine fumarate appears modest but results are promising, researcher says
By Robert Preidt
TUESDAY, April 12, 2016 (HealthDay News) -- An over-the-counterantihistamine used to fight allergies may have an important new role: reversing the vision loss sometimes caused by multiple sclerosis.
That's the finding from preliminary research that found that clemastinefumarate partially reversed optic neuropathy in people with MS.
The study is to be presented April 19 at the American Academy of Neurology's annual meeting in Vancouver.
"While the improvement in vision appears modest, this study is promising because it is the first time a drug has been shown to possibly reverse the damage done by MS," said study author Dr. Ari Green, assistant clinical director of the Multiple Sclerosis Center at the University of California, San Francisco.
The study was small, involving only 50 people averaging 40 years of age. All had been diagnosed with MS for an average of five years and were also diagnosed with optic neuropathy.
For three months, patients received either the antihistamine or aplacebo. The groups were then switched for the last two months of the study.
MS Views and News
Providing educational information and resources for those affected by MS
Keep current with Multiple Sclerosis news and information
To opt-in (sign-up) at our website: click here - thank you